A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients
1 other identifier
interventional
198
1 country
1
Brief Summary
This research study is evaluating a prehabiliation intervention designed to improve postoperative functional capacity (measured by 6-minure walking distance) in individuals undergoing lung resection for cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started May 2021
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedStudy Start
First participant enrolled
May 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJanuary 8, 2024
January 1, 2024
4 years
March 23, 2021
January 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline 6-minute walking distance from baseline to 3-month post-surgery
Baseline; 3-month post-surgery
Secondary Outcomes (18)
Change from baseline 6-minute walking distance at post-intervention
Baseline; 2 weeks (post-intervention)
Change from baseline 6-minute walking distance at 1-month post-surgery
Baseline; 1-months post-surgery
Length of postoperative hospital stay
1-month post-surgery
Postoperative complication
1-month post-surgery
Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at post-intervention
Baseline; 2 weeks (post-intervention)
- +13 more secondary outcomes
Study Arms (2)
Prehabilitation intervention
EXPERIMENTALParticipants in the intervention group will follow a 2-week prehabilitation program before lung resection.
Health education control
ACTIVE COMPARATORParticipants in the control group will receive health education classes during 2 weeks before lung resection.
Interventions
Participants will: * Receive four supervised exercise classes (twice per week for two weeks) one-to-one by an exercise specialist; * Practice six sessions of home-based exercise (three times per week for two weeks); * Practice unsupervised respiratory muscle training at home (twice daily for two weeks); * Receive usual care.
Participants will: * Receive four recorded health education talks (twice per week for two weeks) * Receive a brief health education booklet on dietary education for chronic lung conditions, preoperative preparation, and postoperative recovery * Receive usual care.
Eligibility Criteria
You may qualify if:
- Patients who are diagnosed of stage I, II, or IIIA Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation
- Patients scheduled to undergo lung resection surgery at least two weeks from recruitment
- Patients with a Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 at recruitment
- Patients with no evidence of recurrent or progressive disease
- Patients aged 45-80 years
- Patients able to communicate in Cantonese, Mandarin, or English
- Patients is absence of any cognitive impairment
- Patients with a score of 6 minutes walking test (6MWT) ≤ 500 meters at baseline. \[rationale: a threshold value of 500 meters preoperative 6MWT predicts a higher risk of postoperative complications and prolonged LOS after lung resection\]
- Engagement in less than 150 minutes of moderate aerobic activity per week in the past 3 months
You may not qualify if:
- Patients who had engaged in at least 150 minutes of moderate aerobic activity or 75 minutes of vigorous aerobic activity per week in the past three months
- Presence of another concurrent, actively treated malignancy
- Presence of chronic obstructive pulmonary disease
- Presence of significant comorbidities that impede ability to engage in exercise, such as congestive heart failure, orthopedic disorders of the lower limbs, respiratory failure, or the need for portable oxygen therapy for activities of daily living
- Not having a smart device to receive WhatsApp messages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Head
Study Record Dates
First Submitted
March 23, 2021
First Posted
April 1, 2021
Study Start
May 14, 2021
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
January 8, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share